Advanced search
Publication Cover
Clinical Ophthalmology Volume 14, 2020 - Issue
Submit an article Journal homepage
88
Views
1
CrossRef citations to date
0
Altmetric
Original Research

MOG-IgG- versus AQP4-IgG-Positive Optic Neuritis in Thailand: Clinical Characteristics and Long-Term Visual Outcomes Comparison

Chanomporn Narongkhananukul1 Department of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, ThailandView further author information
,
Tanyatuth Padungkiatsagul1 Department of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, ThailandORCID Iconhttps://orcid.org/0000-0002-5840-6172View further author information
ORCID Icon,
Panitha Jindahra2 Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, ThailandView further author information
,
Chaiyos Khongkhatithum3 Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, ThailandView further author information
,
Lunliya Thampratankul3 Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, ThailandView further author information
&
Kavin Vanikieti1 Department of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence[email protected]
View further author information
Pages 4079-4088 | Published online: 26 Nov 2020

References

  • Woung L, Chung H, Jou J, Wang K, Peng P. A comparison of optic neuritis in Asian and in Western countries. Neuroophthalmology. 2011;35(2):65–72.
  • Fujihara K. Neuromyelitis optica spectrum disorders. Curr Opin Neurol. 2019;32(3):385–394.
  • Peschl P, Bradl M, Höftberger R, Berger T, Reindl M. Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases. Front Immunol. 2017;8:529.
  • Waters P, Komorowski L, Woodhall M, et al. A multicenter comparison of MOG-IgG cell-based assays. Neurology. 2019;92(11):e1250–1255.
  • Cobo-Calvo A, Ruiz A, Maillart E, et al. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults. Neurology. 2018;90(21):e1858–1869.
  • Padungkiatsagul T, Chen J, Jindahra P, et al. Differences in clinical features of myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in White and Asian race. Am J Ophthalmol. 2020;219:332–340.
  • Vanikieti K, Poonyathalang A, Jindahra P, Bouzika P, Rizzo J, Cestari D. Clinical characteristics and long-term visual outcome of optic neuritis in neuromyelitis optica spectrum disorder: a comparison between Thai and American-Caucasian cohorts. Mult Scler Relat Disord. 2017;17:87–91.
  • Zhao G, Chen Q, Huang Y, et al. Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China. J Neurol. 2017;265(1):33–40.
  • Zhao Y, Tan S, Chan T, et al. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients. Br J Ophthalmol. 2018;102(10):1372–1377.
  • Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 2014;71(3):276–283.
  • Ramanathan S, Prelog K, Barnes E, et al. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler. 2016;22(4):470–482.
  • Cobo‐Calvo A, Ruiz A, Rollot F, et al. Clinical features and risk of relapses in children and adults with MOGAD. Ann Neurol. 2020.
  • Ciotti J, Eby N, Wu G, Naismith R, Chahin S, Cross A. Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica. Mult Scler Relat Disord. 2020;45:102399.
  • Song H, Zhou H, Yang M, et al. Different characteristics of aquaporin-4 and myelin oligodendrocyte glycoprotein antibody-seropositive male optic neuritis in China. J Ophthalmol. 2019.
  • Akaishi T, Sato D, Nakashima I, et al. MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study. J Neurol Neurosurg Psychiatry. 2015;87(4):446–448.
  • Chen JJ, Flanagan EP, Jitprapaikulsan J, et al. Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol. 2018;195:8–15.
  • Sotirchos E, Filippatou A, Salama S, et al. MOG-IgG is associated with better visual outcomes after optic neuritis than AQP4-IgG seropositivity, despite similar severity of inner retinal layer thinning. Neurology. 2019;92(15 Supplement):S21.009.
  • Kaneko K, Sato D, Nakashima I, et al. Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies. J Neurol Neurosurg Psychiatry. 2016;87(11):1257–1259.
  • Dale RC, Tantsis EM, Merheb V, et al. Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. Neurol Neuroimmunol Neuroinflamm. 2014;1(1):1–9.
  • Saadoun S, Waters P, Owens GP, Bennett JL, Vincent A, Papadopoulos MC. Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain. Acta Neuropathol Commun. 2014;2(1):35.
  • Pache F, Zimmermann H, Mikolajczak J, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. J Neuroinflammation. 2016;13(1):282.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.